Evidence map›Paper›PMID 40931148›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2025

Socioeconomic inequalities and trends in self-reported hypertension and antihypertensive medication use in Australia between 2009 and 2021: a nationwide population-based cohort study.

Berhe W Sahle, Dianna J Magliano, Andre M N Renzaho, Christopher M Reid, Mark R Nelson, Sandra Nolte, Richard Ofori-Asenso

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Berhe W SahleCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia. berhe.sahle@unimelb.edu.au.
Dianna J MaglianoDiabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Andre M N RenzahoSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
Christopher M ReidSchool of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Mark R NelsonSchool of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Sandra NolteEastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
Richard Ofori-AsensoCardiovascular, Renal, Metabolism Epidemiology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examined trends in the proportion of adults with self-reported hypertension and in antihypertensive medication use among community-dwelling Australian adults. We analysed data from a longitudinal panel study, covering four waves: 2009 (n = 8023), 2013 (n = 11,475), 2017 (n = 12,843), and 2021 (n = 14,571) for adults aged 18-74 years. Hypertension and antihypertensive medication use were self-reported. Healthcare subsidy was defined as the possession of a low-income healthcare card, a Pensioner Concession Card, or a Commonwealth Seniors Health Card. Prevalence estimates were age-standardised to the 2016 Australian Census population. The age-standardised prevalence of hypertension remained stable from 2009 to 2021, i.e., 15.7% (95% confidence interval [CI]: 15.1-16.4) in 2009 versus 15.2% (95% CI: 14.6-15.7) in 2021. Antihypertensive medication use increased from 39.4% (95% CI: 37.0-41.7) in 2009 to 46.7% (95% CI: 44.0-49.3) in 2021 (P

Indexed as

Antihypertensive AgentsHypertensionAdolescentAdultAgedAustraliaCohort StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedPrevalenceSelf ReportSocioeconomic FactorsYoung AdultAntihypertensive AgentsDisparityHealthcare subsidisationHypertensionMedication useSocioeconomic status

Identifiers

PMID40931148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.